# Phase II Randomized Study on Locally Advanced NSCLC Escalated Dose on Individual Basis Treatment With Radiochemotherapy

> **NCT01664663** · PHASE2 · TERMINATED · sponsor: **Ass. Prof. Jan Nyman** · enrollment: 37 (actual)

## Conditions studied

- Non Small Cell Lung Cancer
- Locally Advanced Disease

## Interventions

- **RADIATION:** Standard radiochemotherapy to 68 Gy
- **RADIATION:** Dose escalated radiochemotherapy up to 84 Gy

## Key facts

- **NCT ID:** NCT01664663
- **Lead sponsor:** Ass. Prof. Jan Nyman
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-09
- **Primary completion:** 2013-11
- **Final completion:** 2015-10
- **Target enrollment:** 37 (ACTUAL)
- **Why stopped:** Safety analysis showed increased grade 5 toxicity in experimental arm.
- **Last updated:** 2014-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01664663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01664663, "Phase II Randomized Study on Locally Advanced NSCLC Escalated Dose on Individual Basis Treatment With Radiochemotherapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01664663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*